These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14560766)

  • 21. Influence of vascular access type on outcome measures in patients on maintenance hemodialysis.
    Chand DH; Teo BW; Fatica RA; Brier M;
    Nephron Clin Pract; 2008; 108(2):c91-8. PubMed ID: 18212514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Grzeszczak W; Sulowicz W; Rutkowski B; de Vecchi AF; Scanziani R; Durand PY; Bajo A; Vargemezis V;
    Nephrol Dial Transplant; 2005 May; 20(5):936-44. PubMed ID: 15769814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
    Regidor DL; Kopple JD; Kovesdy CP; Kilpatrick RD; McAllister CJ; Aronovitz J; Greenland S; Kalantar-Zadeh K
    J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH; Fraser C
    Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure.
    Martín Guerrero JD; Olivas ES; Valls GC; Serrano López AJ; Pérez Ruixo JJ; Torres NV
    Comput Biol Med; 2003 Jul; 33(4):361-73. PubMed ID: 12791408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 30. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy.
    Park J; Gage BF; Vijayan A
    Am J Kidney Dis; 2005 Nov; 46(5):791-8. PubMed ID: 16253718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
    Macdougall IC; Temple RM; Kwan JT
    Nephrol Dial Transplant; 2007 Mar; 22(3):784-93. PubMed ID: 16968726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nephrology (Carlton); 2006 Oct; 11(5):394-9. PubMed ID: 17014551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A division algebraic framework for multidimensional support vector regression.
    Shilton A; Lai DT; Palaniswami M
    IEEE Trans Syst Man Cybern B Cybern; 2010 Apr; 40(2):517-28. PubMed ID: 19737676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Training nu-support vector regression: theory and algorithms.
    Chang CC; Lin CJ
    Neural Comput; 2002 Aug; 14(8):1959-77. PubMed ID: 12180409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Barbieri C; Molina M; Ponce P; Tothova M; Cattinelli I; Ion Titapiccolo J; Mari F; Amato C; Leipold F; Wehmeyer W; Stuard S; Stopper A; Canaud B
    Kidney Int; 2016 Aug; 90(2):422-429. PubMed ID: 27262365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-head self-attention mechanism enabled individualized hemoglobin prediction and treatment recommendation systems in anemia management for hemodialysis patients.
    Yang JY; Lee TC; Liao WT; Hsu CC
    Heliyon; 2023 Feb; 9(2):e12613. PubMed ID: 36747539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of East Asian Brain Age using Machine Learning Algorithms Trained With Community-based Healthy Brain MRI.
    Simfukwe C; Youn YC
    Dement Neurocogn Disord; 2022 Oct; 21(4):138-146. PubMed ID: 36407289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.